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a b s t r a c t
In this study, we developed anionic polymer-coated liposome/siRNA complexes (lipoplexes) with
chondroitin sulfate C (CS), poly-L-glutamic acid (PGA) and poly-aspartic acid (PAA) for siRNA delivery
by intravenous injection, and evaluated the biodistribution and gene silencing effect in mice. The sizes of
CS-, PGA- and PAA-coated lipoplexes were about 200 nm and their ζ-potentials were negative. CS-, PGA-
and PAA-coated lipoplexes did not induce agglutination after mixing with erythrocytes. In terms of
biodistribution, siRNAs after intravenous administration of cationic lipoplexes were largely observed in
the lungs, but those of CS-, PGA- and PAA-coated lipoplexes were in both the liver and the kidneys,
indicating that siRNA might be partially released from the anionic polymer-coated lipoplexes in the
blood circulation and accumulate in the kidney, although the lipoplexes can prevent the agglutination
with blood components. To increase the association between siRNA and cationic liposome, we used
cholesterol-modiﬁed siRNA (siRNA-Chol) for preparation of the lipoplexes. When CS-, PGA- and PAA-
coated lipoplexes of siRNA-Chol were injected into mice, siRNA-Chol was mainly observed in the liver,
not in the kidneys. In terms of the suppression of gene expression in vivo, apolipoprotein B (ApoB) mRNA
in the liver was signiﬁcantly reduced 48 h after single intravenous injection of PGA-coated lipoplex of
ApoB siRNA-Chol (2.5mg siRNA/kg), but not cationic, CS- and PAA-coated lipoplexes. In terms of toxicity
after intravenous injection, CS-, PGA- and PAA-coated lipoplexes did not increase GOT and GPT
concentrations in blood. From these ﬁndings, PGA coatings for cationic lipoplex of siRNA-Chol might
produce a systemic vector of siRNA to the liver.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
1. Introduction
RNA interference (RNAi) is a powerful gene-silencing process
that holds great promise in the ﬁeld of gene therapy. Synthetic
small interfering RNAs (siRNAs), which are small double-stranded
RNAs, are substrates for the RNA-induced silencing complex.
However, there are challenges associated with the in vivo delivery
of siRNA, such as enzymatic instability and low cellular uptake. In
siRNA delivery, non-viral vectors such as cationic liposomes and
cationic polymers have been more commonly used than viral
vectors. Of all the carriers, lipid-based formulations such as
cationic liposomes are currently the most widely validated means
for systemic delivery of siRNA to the liver. The liver is an important
organ with a number of potential therapeutic siRNA targets
including cholesterol biosynthesis, ﬁbrosis, hepatitis and hepato-
cellular carcinoma. For efﬁcient siRNA delivery to liver by cationic
liposome, the cationic liposome/siRNA complex (lipoplex) must be
stabilized in the blood by avoiding its agglutination with blood
components, and the pharmacokinetics of lipoplex after intrave-
nous injection must be controlled. This is because electrostatic
interactions between positively charged lipoplex and negatively
charged erythrocytes cause agglutination [1], and the agglutinates
contribute to high entrapment of lipoplex in the highly extended
lung capillaries [2]. PEGylation on the surface of cationic lipoplex
(PEG-modiﬁed lipoplex) can decrease accumulation in the lungs
by preventing association with blood components; however, the
PEGylation abolishes the effect of gene suppression by siRNA
owing to high stability of the lipoplex.
One promising approach for overcoming this problem is
electrostatic encapsulation of cationic lipoplex with anionic bio-
degradable polymers such as chondroitin sulfate (CS) and poly-L-
glutamic acid (PGA). These anionic polymer coatings for lipoplex of
plasmid DNA (pDNA) can prevent the agglutination with blood
components [3,4]. Recently, we developed anionic polymer-coated
lipoplex of pDNA and found that CS and PGA coatings for cationic
lipoplex produced safe systemic vectors [5]. Anionic polymer-
coated lipoplexes have already been developed for pDNA delivery;
however, there is little information about the use of the anionic
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polymer-coated lipoplexes for siRNA delivery. Therefore, in this
study, we prepared anionic polymer-coated lipoplexes with CS,
PGA and poly-aspartic acid (PAA) and examined the biodistribu-
tion and gene silencing effect in the liver after intravenous
injection into mice.
2. Materials and methods
2.1. Materials
1,2-Dioleoyl-3-trimethylammonium-propane methyl sulfate
salt (DOTAP) was obtained from Avanti Polar Lipids Inc. (Alabaster,
AL, USA). Poly-L-glutamic acid sodium salt (PGA, 10.5 kDa) was
purchased from Sigma-Aldrich Co. (St. Louis, MO, USA). Poly-(α,β)-
DL-aspartic acid (PAA, 21 kDa) was obtained from the PolySciTech
division of Akina, Inc. (West Lafayette, IN, USA). Cholesterol (Chol)
and chondroitin sulfate C sodium salt (CS) were purchased from
Wako Pure Chemical Industries, Ltd. (Osaka, Japan). All other
chemicals were of the ﬁnest grade available.
2.2. Cell culture
Human breast cancer MCF-7-Luc (TamR-Luc#1) cells stably
expressing ﬁreﬂy luciferase (pGL3) were donated by Dr. Kazuhiro
Ikeda (Division of Gene Regulation and Signal Transduction,
Research Center for Genomic Medicine, Saitama Medical Univer-
sity, Saitama, Japan) [6]. The cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM), supplemented with 10% heat-
inactivated fetal bovine serum (FBS), 100 mg/ml kanamycin and 0.5
mg/ml G418 at 37 1C in a 5% CO2 humidiﬁed atmosphere.
2.3. siRNA
siRNAs targeting nucleotides of ﬁreﬂy pGL3 luciferase (Luc siRNA),
Cy5.5-labeled Luc siRNA (Cy5.5-siRNA), Luc siRNA conjugated with
cholesterol (Luc siRNA-Chol), Cy5.5-labeled Luc siRNA conjugated
with cholesterol (Cy5.5-siRNA-Chol), nonsilencing siRNA (Cont siRNA)
as a negative control for Luc siRNA, Cont siRNA conjugated with
cholesterol (Cont siRNA-Chol) as a negative control for Luc siRNA-Chol,
cholesterol-modiﬁed apolipoprotein B siRNA (ApoB siRNA-Chol) and
Cont siRNA-Chol as a negative control for ApoB siRNA-Chol were
synthesized by Sigma Genosys (Tokyo, Japan). The siRNA sequences of
the Luc siRNA were as follows: sense strand: 50-GUGGAUUUCGAGUC-
GUCUUAA-30, and antisense strand: 50-AAGACGACUCGAAAUCCACAU-
3. In Cy5.5-siRNA and Cy5.5-siRNA-Chol, Cy5.5 dye was conjugated at
the 50-end of the sense strand, and cholesterol was at the 30-end of the
sense strand. The siRNA sequences of the Cont siRNA were as
follows: sense strand: 50-GUACCGCACGUCAUUCGUAUC-30, and anti-
sense strand: 50-UACGAAUGACGUGCGGUACGU-30 [7]. In Luc siRNA-
Chol and Cont siRNA-Chol, cholesterol was conjugated at the 30-end of
the sense strand. The siRNA sequences of the apolipoprotein B (ApoB)
siRNA-Chol were as follows [8]: sense strand: 50-GUCAUCACACU-
GAAUACCAAU*Chol-30, and antisense strand: 50-AUUGGUAUUCAGU-
GUGAUGAc*a*C-30. The siRNA sequences of the Cont siRNA-Chol were
as follows : sense strand: 50-GAACUGUGUGUGAGAGGUCCU*Chol-30,
and antisense strand: 50-AGGACCUCUCACACACAGUUc*g*C-30. The
lower-case letters represent 20-O-methyl-modiﬁed nucleotides; aster-
isks represent phosphorothioate linkages.
2.4. Preparation of liposome and lipoplex
Cationic liposome was prepared from DOTAP/Chol at a molar
ratio of 1/1 by a thin-ﬁlm hydration method, as previously
reported [9,10]. For preparation of rhodamine-labeled cationic
liposome, Lissamine™ rhodamine B 1,2-dihexadecanoyl-sn-
glycero-3-phosphoethanolamine, triethylammonium salt (rhoda-
mine-DHPE, Invitrogen, Carlsbad, CA, USA) was incorporated at 1
mol% into the total lipids. The particle size and ζ-potential of
cationic liposomes were measured by dynamic light-scattering
and electrophoresis light-scattering methods, respectively (ELS-
Z2, Otsuka Electronics Co., Ltd., Osaka, Japan). The size of the
cationic liposomes was adjusted to approximately 80 nm.
To prepare cationic liposome/siRNA complex (cationic lipo-
plex), cationic liposome suspension was mixed with siRNA by
vortex-mixing for 10 s at a charge ratio (/þ) of 1/4, and left for
15min at room temperature. The theoretical charge ratio (/þ) of
siRNA to cationic liposome was calculated as the molar ratio of
siRNA phosphate to DOTAP nitrogen. To prepare ternary com-
plexes with anionic polymers, cationic lipoplex was mixed with
CS, PGA and PAA solutions (CS-, PGA- and PAA-coated lipoplexes,
respectively) at the indicated charge ratios. The theoretical charge
ratios (/þ) of CS, PGA and PAA to DOTAP were calculated as the
molar ratios of sulfate and carboxylic acid of CS (two negative
charges per disaccharide unit), carboxylic acid of PGA (one
negative charge per glutamic acid) and carboxylic acid of PAA
(one negative charge per aspartic acid) to nitrogen of DOTAP,
respectively.
2.5. Gel retardation assay
After preparation of the cationic lipoplexes, CS-, PGA- and PAA-
coated lipoplexes of 1 mg of siRNA or siRNA-Chol at the indicated
charge ratios (/þ) of anionic polymer and siRNA to DOTAP, they
were analyzed on an 18% acrylamide gel for siRNA in Tris–borate–
EDTA (pH 8.0) buffer and were visualized by ethidium bromide
staining, as previously reported [11].
2.6. Accessibility of siRNA in lipoplexes
siRNA condensation by anionic polymer-coated lipoplexes was
analyzed by exclusion assay using an SYBRs Green I Nucleic Acid
Gel Stain (Takara Bio Inc., Shiga, Japan), as previously reported [11].
The anionic polymer-coated lipoplexes of 1 mg of siRNA at various
charge ratios (/þ) in a volume of 100 mL of Tris–HCl buffer (pH
8.0) were mixed with 100 mL of 2500-fold diluted SYBRs Green
I Nucleic Acid Gel Stain solution with Tris–HCl buffer, and then
incubated for 30min. The ﬂuorescence was measured at an
emission wavelength of 521 nm with an excitation wavelength of
494 nm using a ﬂuorescent spectrophotometer, F-2700 (Hitachi
Co., Ltd., Tokyo, Japan). As a control, the value of ﬂuorescence
obtained upon addition of 5 mg/ml free siRNA solution was set as
100%. The amount of siRNA available to interact with the SYBRs
Green I is expressed as a percentage of the control.
2.7. Luciferase activity
MCF-7-Luc cells were prepared by plating cells in a 6-well plate
24 h prior to each experiment. For transfection, each lipoplex of
200 pmol Luc siRNA, Luc-siRNA-Chol, Cont siRNA or Cont siRNA-
Chol was diluted in 2ml of medium supplemented with 10% FBS
and then the mixture was added into the cells. Lipofectamine
RNAiMax lipoplex (Invitrogen Corp.) was prepared according to
the manufacturer’s protocol. Forty-eight hours after the transfec-
tion, luciferase activity was measured as counts per s (cps)/mg
protein using the luciferase assay system (Pica gene luciferase
assay kit; Toyo Ink Mfg. Co., Ltd.) and BCA reagent (Pierce, Rock-
ford, IL, USA), as previously reported [11].
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2.8. Agglutination assay
Agglutination assay was performed according to the method
described in a previous report [5]. Brieﬂy, erythrocytes were
collected from mouse blood at 4 1C by centrifugation at 300g for
3min and resuspended in PBS as a 2% (v/v) stock suspension of
erythrocytes. The anionic polymer-coated lipoplexes of 2 mg of
Cont siRNA or siRNA-Chol were added to 100 mL of erythrocyte
suspension and then incubated for 15min at 37 1C. The sample
was placed on a glass plate and agglutination was observed by
microscopy.
2.9. Biodistribution of anionic polymer-coated lipoplexes in mice
All animal experiments were performed with approval from
the Institutional Animal Care and Use Committee of Hoshi Uni-
versity. Cationic and anionic polymer-coated lipoplexes of 50 mg of
Cy5.5-siRNA or Cy5.5-siRNA-Chol were intravenously adminis-
tered via lateral tail veins into female BALB/c mice (7 weeks of
age; Sankyo Lab. Service Corp., Tokyo, Japan). One hour after
injection, the mice were sacriﬁced, and the tissues were frozen
on dry ice and sliced at 16 mm. The localization of Cy5.5-siRNA was
examined using an Eclipse TS100-F microscope (Nikon, Tokyo,
Japan).
2.10. Knockdown of liver-speciﬁc ApoB mRNA in vivo
Anionic polymer-coated lipoplexes of 50mg of Cont siRNA-Chol or
ApoB siRNA-Chol were intravenously administered via lateral tail veins
into mice. At 24h post-injection, mice were fasted for 24 h. At 48h
post-injection, mice were sacriﬁced by cervical dislocation and the
liver was removed for analysis. Total RNA was isolated from the liver
using the NucleoSpin RNA II (Macherey-Nagel, Germany). Mouse
ApoB cDNA was ampliﬁed using the primers ApoB-FW, 50-TTCCAGC-
CATGGGCAACTTTACCT-30, and ApoB-RW, 50-TACTGCAGGGCGTC
AGTGACAAAT-30, as previously reported [12]. Mouse β-actin cDNA
was ampliﬁed using the primers β-actin-FW, 50-TGTGATGGTGG-
GAATGGGTCAG-30, and β-actin-RW, 50-TTTGATGTCACGCACGATTTCC-
30, as previously reported [13]. Quantitative RT-PCR was performed
with the iCycler MyiQ detection system (Bio-Rad Laboratories, Her-
cules, CA, USA) and the SYBR Green I assay (iQ™ SYBER Green
Supermix, Bio-Rad Laboratories), as previously described [13]. Samples
were run in triplicate and the mRNA expression levels of ApoB were
normalized to the amount of β-actin mRNA in the same sample. A
difference of 1 cycle was considered to represent a 2-fold change in
gene expression.
2.11. Serum cholesterol level
PGA-coated lipoplexes of 50 mg of ApoB siRNA-Chol were
intravenously administered via lateral tail veins into mice. At 24
h post-injection, mice were fasted for 24 h. At 48 h post-injection,
blood was collected from the carotid arteries of mice under
anesthesia, and allowed to stand for 1 h at 37 1C. Serum low-
density-lipoprotein (LDL) cholesterol level was measured using a
commercial LDL cholesterol detection kit according to the manu-
facturer’s instructions (HDL and LDL/VLDL Cholesterol Quantiﬁca-
tion Kit, Bio Vision Incorporated, Milpitas, CA, USA).
2.12. Determination of plasma transaminase activities
Serum was prepared by separation of the coagulated whole
blood of female C57BL/6Cr mice (7 weeks of age; Sankyo Lab.
Service Corp., Tokyo, Japan) 24 h after intravenous injection of
cationic and anionic polymer-coated lipoplexes of 50 mg of Cont
siRNA-Chol. Aspartate aminotransferase (AST/GOT) and alanine
aminotransferase (ALT/GPT) activities in the plasma were deter-
mined using commercially available test reagents (GPT-UV test
Wako and GPT-UV test Wako, respectively; Wako, Osaka, Japan).
Normal values were determined using blood obtained from age-
matched, untreated mice.
2.13. Statistical analysis
The statistical signiﬁcance of differences between mean values
was determined by using Student’s t-test. A p value of 0.05 or less
was considered signiﬁcant.
3. Results and discussion
3.1. Particle size and ζ-potential of various anionic polymer-coated
lipoplexes
The cationic lipid, 1,2-dioleoyl-3-trimethylammonium propane
(DOTAP), has frequently been used as a cationic lipid for a
liposomal delivery system of siRNA by several research groups
[14–17]. Among cationic liposomes, DOTAP/Chol liposome is
commercially supplied as an in vivo transfection reagent (e.g.,
in vivo MegaFectin™ from Qbiogene Molecular Biology, in vivo
Liposome Transfection Reagent from Sigma-Aldrich), which was
demonstrated to have high transfection efﬁciency in the lungs by
intravenous injection. Here, we selected chondroitin sulfate C (CS),
poly-L-glutamic acid (PGA) and poly-aspartic acid (PAA) as materi-
als for coating cationic DOTAP/Chol lipoplexes of siRNA and
evaluated their potential for use as an siRNA delivery vector.
First, we prepared DOTAP/Chol liposome andmeasured the particle
size and ζ-potential. The liposome size was about 80nm and the ζ-
potential was þ50mV. When the liposomes were mixed with siRNA,
the lipoplex size was about 280nm and the ζ-potential was þ40mV.
Next, we coated the lipoplexes with anionic polymers, CS, PGA and
PAA, at various charge ratios (/þ), and prepared CS-, PGA- and PAA-
coated lipoplexes. With increasing amounts of CS, PGA and PAA being
added to the lipoplex, their sizes decreased to 150–200nm and ζ-
potential to a negative value (Fig. 1A–C). Although the sizes of CS-,
PGA- and PAA-coated lipoplexes were smaller than that of cationic
lipoplex, the anionic polymers may be able to strongly compact the
cationic lipoplex by the electrostatic interaction. The ζ-potentials of
the lipoplexes after the addition of anionic polymers were almost
consistently negative around charge ratios (/þ) of 1 in CS, 1.5 in PGA
and 1.5 in PAA, indicating that nitrogen of cationic lipoplex was
completely covered with a sulfate group or a carboxyl group of the
anionic polymers. In a previous study, we reported that ζ-potentials of
the lipoplexes of pDNA after the addition of anionic polymers were
almost consistently negative around charge ratios (/þ) of 5.8 in CS
and 7 in PGA [5]. The amount of anionic polymer needed for covering
cationic lipoplex of siRNA was sufﬁcient at a lower level than for the
lipoplex of pDNA. Therefore, in subsequent experiments, we decided
to use 1 in CS, 1.5 in PGA and 1.5 in PAA as optimal charge ratios
(/þ) for the preparation of anionic polymer-coated lipoplex.
3.2. Association of siRNA with the liposome
The association of siRNA with cationic liposome was monitored
by gel retardation electrophoresis. Naked siRNA was detected as
bands on acrylamide gel. Beyond a charge ratio (/þ) of
1/3, no migration of siRNA was observed for cationic lipoplex
(Fig. 2A). However, migration of siRNA was observed for CS-, PGA-
and PAA-coated lipoplexes at all charge ratios (/þ) of
anionic polymer/DOTAP when anionic polymers were added into
cationic lipoplex (Fig. 2B), indicating that anionic polymers caused
dissociation of siRNA from lipoplex by competition for binding to
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cationic liposome. Previously, we reported that CS and PGA could
coat cationic lipoplex of pDNA without releasing pDNA from the
cationic lipoplex, and formed stable anionic lipoplexes [5]. In
lipoplex of siRNA, the association of cationic liposome with siRNA
might be weaker than that with pDNA.
Furthermore, we examined the association of siRNA with
cationic liposome using SYBRs Green I. SYBRs Green I is a DNA/
RNA-intercalating agent whose ﬂuorescence is dramatically
enhanced upon binding to siRNA and quenched when displaced
by condensation of the siRNA structure. Unlike gel retardation
electrophoresis, ﬂuorescence of SYBRs Green I was markedly
decreased by the formation of anionic polymer-coated lipoplex,
compared with that in siRNA solution (Supplemental Fig. S1).
These ﬁndings suggested that the CS-, PGA- and PAA-coated
lipoplexes were completely formed even at charge ratios (/þ)
of 1, 1.5 and 1.5, respectively. Although a discrepancy between the
results from the accessibility of SYBRs Green I and gel retardation
electrophoresis was observed, siRNA might be released from the
anionic polymer-coated lipoplex under electrophoresis by weak
association between siRNA and cationic liposomes.
To increase the association between siRNA and cationic lipo-
some, we decided to use siRNA-Chol for the preparation of anionic
polymer-coated lipoplex. In siRNA-Chol, beyond a charge ratio
(/þ) of 1/1, no migration of siRNA was observed for cationic
lipoplex (Fig. 2A). Furthermore, no migration of siRNA-Chol was
observed at CS-, PGA- and PAA-coated lipoplexes, even at a charge
ratio (/þ) of 10/1, when anionic polymers were added into
cationic lipoplex of siRNA-Chol formed at a charge ratio (/þ) of
1/4 (Fig. 2B). From these results, we conﬁrmed that CS, PGA and
PAA could coat cationic lipoplex without releasing siRNA-Chol
from the cationic lipoplex, and formed stable anionic lipoplexes.
When anionic polymer-coated lipoplexes of siRNA-Chol were
prepared at charge ratios (/þ) of 1 in CS, 1.5 in PGA and 1.5 in
PAA, the sizes and ζ-potentials of CS-, PGA- and PAA-coated
lipoplexes were 299, 233 and 235 nm, and 22.8, 36.7 and
54.3mV, respectively (Supplemental Table S1). In subsequent
experiments, we decided to use anionic polymer-coated lipoplexes
of siRNA and siRNA-Chol for comparison of transfection activity
and biodistribution.
3.3. In vitro transfection efﬁciency
Generally, in cationic lipoplexes, strong electrostatic interaction
with a negatively charged cellular membrane can contribute to
high siRNA transfer through endocytosis. To investigate whether
anionic polymer-coated lipoplexes could be taken up well by cells
and induce gene suppression by siRNA, we examined the gene
knockdown effect using a luciferase assay system with MCF-7-Luc
cells. Cationic lipoplex of Luc siRNA or Luc siRNA-Chol exhibited
moderate suppression of luciferase activity; however, coating of
anionic polymers on the cationic lipoplex caused disappearance of
gene knockdown efﬁcacy by cationic lipoplex (Fig. 3A and B),
suggesting that negatively charged lipoplexes were not taken up
by the cells because they repulsed the cellular membrane
electrostatically.
3.4. Interaction with erythrocytes
Cationic lipoplex often lead to the agglutination of erythrocytes
by the strong afﬁnity of positively charged lipoplex to the cellular
membrane. To investigate whether polymer coatings for cationic
lipoplex could prevent agglutination with erythrocytes, we
observed the agglutination of anionic polymer-coated lipoplex
with erythrocytes by microscopy (Fig. 4). CS-, PGA- and PAA-
coated lipoplexes of siRNA or siRNA-Chol showed no agglutination,
although cationic lipoplexes did. This result indicated that the
negatively charged surface of anionic polymer-coated lipoplexes
could prevent the agglutination with erythrocytes.
3.5. Biodistribution of siRNA after injection of lipoplex
We intravenously injected anionic polymer-coated lipoplexes of
Cy5.5-siRNA or Cy5.5-siRNA-Chol into mice, and observed the biodis-
tribution of siRNA at 1h after the injection by ﬂuorescent microscopy.
When naked siRNA and siRNA-Chol were injected, the accumulations
were strongly observed only in the kidneys (Figs. 5 and 6), indicating
that naked siRNAwas quickly eliminated from the body by ﬁltration in
the kidneys. For siRNA lipoplex, cationic lipoplex was largely accumu-
lated in the lungs. CS, PGA and PAA coatings of cationic lipoplex
decreased the accumulation of siRNA in the lungs and increased it in
the liver and the kidneys (Fig. 5). To conﬁrm whether siRNA observed
in the kidneys was siRNA or lipoplex of siRNA, we prepared cationic
and PGA-coated lipoplexes using rhodamine-labeled liposome and
Fig. 2. Association of siRNA with cationic liposome after coating with various
anionic polymers. (A) Cationic lipoplexes of 1 mg of siRNA or siRNA-Chol at various
charge ratios (þ/) were analyzed by 18% acrylamide gel electrophoresis. Charge
ratio (/þ) indicates the molar ratios of siRNA phosphate to DOTAP nitrogen.
(B) Anionic polymer-coated lipoplexes of 1 mg of siRNA or siRNA-Chol at various
charge ratios (/þ) were analyzed by 18% acrylamide gel electrophoresis. Charge
ratio (/þ) indicates the molar ratios of sulfate and/or carboxylic acid of anionic
polymers/DOTAP nitrogen.
Fig. 1. Effect of charge ratio of anionic polymer to cationic lipoplex of siRNA on
particle size and ζ-potential of anionic polymer-coated lipoplexes. Charge ratio
(/þ) indicates the molar ratios of sulfate and/or carboxylic acid of anionic
polymers/nitrogen of DOTAP.
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Cy5.5-siRNA, and the localizations of siRNA and liposome after
intravenous injection were observed by ﬂuorescent microscopy
(Supplemental Fig. S2). When cationic lipoplex was intravenously
injected into mice, both the siRNA and the liposome were mainly
detected in the lungs, and the localizations of siRNA were almost
identical to those of the liposome, indicating that most of the siRNA
was distributed in the tissues as a lipoplex. In contrast, when PGA-
coated lipoplex was intravenously injected, siRNA was strongly
detected in both the liver and the kidneys, but the liposomes were
mainly in the liver. From this ﬁnding, although anionic polymer
coatings prevent the accumulation of lipoplex in the lungs by
inhibiting interaction with erythrocytes, siRNA dissociated from anio-
nic polymer-coated lipoplexes in blood may accumulate in the
kidneys. In contrast to siRNA lipoplex, CS, PGA and PAA coatings of
cationic lipoplex of siRNA-Chol induced the high accumulation of
siRNA-Chol in the liver, but diminished ﬂuorescence of siRNA was
observed in the kidneys compared with the lipoplexes of siRNA
(Fig. 6). From this result, CS-, PGA- and PAA-coated lipoplexes of
siRNA-Chol might have potential as a targeting vector of siRNA to
the liver.
3.6. Gene suppression in vivo
To investigate whether anionic polymer-coated lipoplex of
siRNA-Chol could suppress the expression of a targeted gene in
the liver, we chose to target the mouse ApoB gene, a hepatocyte-
expressed gene involved in cholesterol transport, and evaluated
the knockdown efﬁciency into mice by assaying the level of ApoB
mRNA at 48 h after intravenous injection of anionic polymer-
coated lipoplex of ApoB siRNA-Chol (Fig. 7). The injections of
naked ApoB siRNA-Chol, cationic, CS- and PAA-coated lipoplexes of
ApoB siRNA-Chol did not affect the ApoB mRNA level in the liver
compared with those of Cont siRNA-Chol, respectively. In contrast,
the injection of PGA-coated lipoplex of ApoB siRNA-Chol could
Fig. 4. Agglutination of anionic polymer-coated lipoplexes of siRNA or siRNA-Chol with erythrocytes. Each lipoplex was added to erythrocytes, and agglutination was
observed by phase contrast microscopy. Arrows indicate agglutination. Scale bar ¼ 100 mm.
Fig. 3. Gene suppression in MCF-7-Luc cells by anionic polymer-coated lipoplexes. Cationic, CS, PGA and PAA-coated lipoplexes of siRNA (A) and siRNA-Chol (B) were added
to MCF-7-Luc cells at 100 nM siRNA, and the luciferase assay was carried out 48 h after incubation. Statistical signiﬁcance was evaluated by Student’s t test. **p o 0.01,
compared with Cont siRNA. Each column represents the mean 7 S.D. (n ¼ 3).
Fig. 5. Biodistribution of Cy5.5-siRNA at 1 h after intravenous administration by
anionic polymer-coated lipoplexes into mice. Green signals indicate localization of
Cy5.5-siRNA. Scale bar ¼ 100 mm.
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signiﬁcantly induce suppression of the ApoB mRNA level in the
liver compared with that of Cont siRNA-Chol (about 40%
knockdown).
ApoB is an essential protein in the formation of LDL in the
metabolism of dietary and endogenous cholesterol. Therefore, we
measured the LDL level in serum 48 h after treatment with PGA-
coated lipoplex of ApoB siRNA-Chol. This treatment of mice
resulted in an approximately 34% reduction (0.073 7 0.021mg/
ml), compared with no treatment (0.112 7 0.027mg/ml) (data not
shown). This result indicated that the reduction of ApoB level in
the liver induced a decrease of LDL cholesterol level in serum.
It was not clear why CS- and PAA-coated lipoplexes did not
induce a gene silencing effect. HARE/Stab-2 is known as the
primary scavenger receptor for systemic turnover of most types
of CS, which is found primarily in the sinusoidal endothelial cells
of the liver [18]. With regard to CS-coated lipoplex, it might be
captured by the sinusoidal endothelial cells in the liver, and not be
delivered to hepatocytes.
3.7. Serum GOT and GPT concentrations
Finally, for evaluation of toxicity to mice, we assessed GOT and
GPT levels in serum after intravenous injection of cationic, CS-,
PGA- and PAA-coated lipoplexes. Loisel et al. reported that cationic
lipoplexes prepared with cationic lipids as DOTAP and cationic
phospholipid compounds induced toxic effects in liver [19]. When
cationic lipoplexes were intravenously injected into mice,
increased concentration of GOT and GPT in blood were observed
at 24 h, but not after injection of naked siRNA-Chol, CS-, PGA- and
PAA-coated lipoplexes (Fig. 8A and B). These results suggested that
CS-, PGA and PAA-coated lipoplexes had less side effects with
regard to hepatoxicity by intravenous injection compared to
cationic lipoplexes.
Previously, naked ApoB siRNA-Chol showed a signiﬁcant reduc-
tion of the level of ApoB mRNA (57% reduction) in the liver
compared with that in a saline control when it was intravenously
injected into mice at 50mg siRNA/kg (1mg per mouse) [8]. In this
study, we synthesized and used the same chemically modiﬁed
ApoB siRNA-Chol as in the previous report for an experiment on
ApoB mRNA suppression; however, naked ApoB siRNA-Chol did
not show reduction of the level of ApoB mRNA (Fig. 7). This can be
explained by the difference in injected dose of ApoB siRNA-Chol in
this study (2.5mg siRNA/kg, 50 mg per mouse). This ﬁnding indi-
cates that PGA-coated lipoplex of siRNA-Chol could deliver siRNA
to hepatocytes and suppress ApoB expression at a 1/20-fold dose
of naked siRNA-Chol without hepatoxicity. Although PGA-coated
lipoplex of siRNA-Chol did not induce gene suppression in vitro
(Fig. 3B), it had potential for in vivo delivery of siRNA-Chol into
liver by intravenous injection.
4. Conclusion
In this study, we developed anionic polymer-coated DOTAP/
Chol lipoplexes for systemic gene delivery of siRNA. Among them,
PGA coating for cationic lipoplex of siRNA-Chol induced accumula-
tion in the liver after intravenous injection, and could suppress the
mRNA level of the targeted gene. From our results, PGA-coated
lipoplex might be an outstanding tool for safe siRNA delivery to
the liver. Further study should be performed to examine the
increase of the gene silencing effect in the liver and further
therapeutic applications.
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